FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2252793234> ?p ?o ?g. }

• W2252793234 endingPage "8066" @default.
• W2252793234 startingPage "8055" @default.
• W2252793234 abstract "// Byungho Lim 1, * , Chan Kim 2, 3, * , Jeong-Hwan Kim 4 , Woo Sun Kwon 3 , Won Seok Lee 3 , Jeong Min Kim 3 , Jun Yong Park 5 , Hyo Song Kim 2 , Kyu Hyun Park 3 , Tae Soo Kim 3 , Jong-Lyul Park 4 , Hyun Cheol Chung 2, 3, 6 , Sun Young Rha 2, 3, 6 , Seon-Young Kim 1, 7 1 Genome Structure Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea 2 Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea 3 Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea 4 Epigenomics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea 5 Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea 6 Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea 7 Department of Functional Genomics, University of Science and Technology, Daejeon, Korea * These authors have contributed equally to this work Correspondence to: Seon-Young Kim, e-mail: kimsy@kribb.re.kr Sun Young Rha, e-mail: rha7655@yuhs.ac Keywords: exome sequencing, gastric cancer, malignant ascites, peritoneal carcinomatosis, somatic mutation Received: June 22, 2015      Accepted: January 07, 2016      Published: January 22, 2016 ABSTRACT Peritoneal carcinomatosis accompanied by malignant ascites is a major cause of death of advanced gastric cancer (GC). To comprehensively characterize the underlying genomic events involved in GC peritoneal carcinomatosis, we analyzed whole-exome sequences of normal gastric tissues, primary tumors, and malignant ascites from eight GC patients. We identified a unique mutational signature biased toward C-to-A substitutions in malignant ascites. In contrast, the patients who received treatment of adjuvant chemotherapy showed a high rate of C-to-T substitutions along with hypermutation in malignant ascites. Comparative analysis revealed several candidate mutations for GC peritoneal carcinomatosis: recurrent mutations in COL4A6 , INTS2 , and PTPN13 ; mutations in druggable genes including TEP1, PRKCD, BRAF, ERBB4, PIK3CA, HDAC9, FYN, FASN, BIRC2, FLT3, ROCK1, CD22 , and PIK3C2B ; and mutations in metastasis-associated genes including TNFSF12, L1CAM, DIAPH3, ROCK1, TGFBR1, MYO9B, NR4A1 , and RHOA . Notably, gene ontology analysis revealed the significant enrichment of mutations in the Rho-ROCK signaling pathway-associated biological processes in malignant ascites. At least four of the eight patients acquired somatic mutations in the Rho-ROCK pathway components, suggesting the possible relevance of this pathway to GC peritoneal carcinomatosis. These results provide a genome-wide molecular understanding of GC peritoneal carcinomatosis and its clinical implications, thereby facilitating the development of effective therapeutics." @default.
• W2252793234 created "2016-06-24" @default.
• W2252793234 creator A5018583230 @default.
• W2252793234 creator A5024576109 @default.
• W2252793234 creator A5024676627 @default.
• W2252793234 creator A5029889356 @default.
• W2252793234 creator A5035238172 @default.
• W2252793234 creator A5038994402 @default.
• W2252793234 creator A5047330848 @default.
• W2252793234 creator A5049575773 @default.
• W2252793234 creator A5063234359 @default.
• W2252793234 creator A5064404544 @default.
• W2252793234 creator A5068344018 @default.
• W2252793234 creator A5070060016 @default.
• W2252793234 creator A5074546833 @default.
• W2252793234 creator A5078554180 @default.
• W2252793234 date "2016-01-22" @default.
• W2252793234 modified "2023-10-16" @default.
• W2252793234 title "Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites" @default.
• W2252793234 cites W1953186510 @default.
• W2252793234 cites W1965619419 @default.
• W2252793234 cites W1965856472 @default.
• W2252793234 cites W1970195787 @default.
• W2252793234 cites W1979115864 @default.
• W2252793234 cites W1984746891 @default.
• W2252793234 cites W1985627474 @default.
• W2252793234 cites W1993145790 @default.
• W2252793234 cites W1995249913 @default.
• W2252793234 cites W2000174712 @default.
• W2252793234 cites W2006288875 @default.
• W2252793234 cites W2007490905 @default.
• W2252793234 cites W2007897263 @default.
• W2252793234 cites W2011912935 @default.
• W2252793234 cites W2017863062 @default.
• W2252793234 cites W2024913322 @default.
• W2252793234 cites W2032954163 @default.
• W2252793234 cites W2033842957 @default.
• W2252793234 cites W2058689904 @default.
• W2252793234 cites W2064724248 @default.
• W2252793234 cites W2067651633 @default.
• W2252793234 cites W2075953339 @default.
• W2252793234 cites W2076809063 @default.
• W2252793234 cites W2086072858 @default.
• W2252793234 cites W2086775982 @default.
• W2252793234 cites W2103441770 @default.
• W2252793234 cites W2107037361 @default.
• W2252793234 cites W2111326065 @default.
• W2252793234 cites W2115276344 @default.
• W2252793234 cites W2119180969 @default.
• W2252793234 cites W2126303005 @default.
• W2252793234 cites W2126547130 @default.
• W2252793234 cites W2126895968 @default.
• W2252793234 cites W2133773373 @default.
• W2252793234 cites W2135449254 @default.
• W2252793234 cites W2138601221 @default.
• W2252793234 cites W2146290346 @default.
• W2252793234 cites W2159391562 @default.
• W2252793234 cites W64385 @default.
• W2252793234 doi "https://doi.org/10.18632/oncotarget.6977" @default.
• W2252793234 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4884975" @default.
• W2252793234 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26811494" @default.
• W2252793234 hasPublicationYear "2016" @default.
• W2252793234 type Work @default.
• W2252793234 sameAs 2252793234 @default.
• W2252793234 citedByCount "38" @default.
• W2252793234 countsByYear W22527932342016 @default.
• W2252793234 countsByYear W22527932342017 @default.
• W2252793234 countsByYear W22527932342018 @default.
• W2252793234 countsByYear W22527932342019 @default.
• W2252793234 countsByYear W22527932342020 @default.
• W2252793234 countsByYear W22527932342021 @default.
• W2252793234 countsByYear W22527932342022 @default.
• W2252793234 countsByYear W22527932342023 @default.
• W2252793234 crossrefType "journal-article" @default.
• W2252793234 hasAuthorship W2252793234A5018583230 @default.
• W2252793234 hasAuthorship W2252793234A5024576109 @default.
• W2252793234 hasAuthorship W2252793234A5024676627 @default.
• W2252793234 hasAuthorship W2252793234A5029889356 @default.
• W2252793234 hasAuthorship W2252793234A5035238172 @default.
• W2252793234 hasAuthorship W2252793234A5038994402 @default.
• W2252793234 hasAuthorship W2252793234A5047330848 @default.
• W2252793234 hasAuthorship W2252793234A5049575773 @default.
• W2252793234 hasAuthorship W2252793234A5063234359 @default.
• W2252793234 hasAuthorship W2252793234A5064404544 @default.
• W2252793234 hasAuthorship W2252793234A5068344018 @default.
• W2252793234 hasAuthorship W2252793234A5070060016 @default.
• W2252793234 hasAuthorship W2252793234A5074546833 @default.
• W2252793234 hasAuthorship W2252793234A5078554180 @default.
• W2252793234 hasBestOaLocation W22527932341 @default.
• W2252793234 hasConcept C104317684 @default.
• W2252793234 hasConcept C121608353 @default.
• W2252793234 hasConcept C126322002 @default.
• W2252793234 hasConcept C142724271 @default.
• W2252793234 hasConcept C143998085 @default.
• W2252793234 hasConcept C163763905 @default.
• W2252793234 hasConcept C16671776 @default.
• W2252793234 hasConcept C2780265364 @default.
• W2252793234 hasConcept C501734568 @default.

• next